EP Patent

EP0414920B1 — Aerosol preparation for external use

Assigned to Taisho Pharmaceutical Co Ltd · Expires 1997-05-14 · 29y expired

What this patent protects

The present invention provides a new aerosol preparation for external use mainly directed to skin cooling, which forms sherbet-like foams when sprayed. The stock solution is composed of a mixture of water with a lower alcohol as the base and a mixture of liquefied petroleum gas w…

USPTO Abstract

The present invention provides a new aerosol preparation for external use mainly directed to skin cooling, which forms sherbet-like foams when sprayed. The stock solution is composed of a mixture of water with a lower alcohol as the base and a mixture of liquefied petroleum gas with dimethyl ether as the propellant, blended in a specified compositional ratio so as to form sherbet-like foams. This aerosol preparation is expected to exhibit a combined effect of the aerosol preparation as the coolant and the main ingredient as the drug. It is especially excellent in its application to the affected part of a human body as compared with the conventional aerosol preparations for external use which are sprayed as droplets.

Drugs covered by this patent

Patent Metadata

Patent number
EP0414920B1
Jurisdiction
EP
Classification
Expires
1997-05-14
Drug substance claim
No
Drug product claim
No
Assignee
Taisho Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.